Titlebook: Locoregional Tumor Therapy; Eric Van Cutsem,Thomas J. Vogl,Alberto Sobrero Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 HCC

JIBE

Embolization Materials, Catheters, and Intra-arterial Portsinclude locoregional, tumoricidal therapies, pre-, or postoperative adjunctive treatments as well as palliative management options. Although different materials are used depending on the indications, the interventional approach is in most of the cases similar: a diagnostic catheter is placed in the

消極詞匯

HCCated death, and accounts for 7 % of all cancers [1]. HCC represents more than 90 % of primary liver cancers and is a major global health problem. Over the last three decades, the age-adjusted incidence of liver cancer has risen to 4.6 per 100,000 individuals. The incidence of HCC will likely continu

漫不經(jīng)心

CRC Liver Metastaseslly detectable liver metastases at the initial diagnosis and approximately 50 % develop liver metastases during their disease course, with median survival rates of less than 8 months, without any treatment [2, 3]. Currently, complete surgical resection plus perioperative chemotherapy, sometimes in c

堅毅

SOBER

Liver Metastases of Other Indicationsspecially for the less usual that are presented in this chapter, the aim is to increase the amount of the drug delivered to the tumor and to decrease systemic toxicity. On the other hand, locoregional treatment in these specific settings may help to increase the activity of the drug especially for r

gustation

Chemoembolization of Lung Tumorside. In the United States, bronchogenic carcinoma is the second most common cancer for both men and women. In 2002, 169,400 new cases of bronchogenic carcinoma were diagnosed in the United States, and 154,900 people died of this disease, making bronchogenic carcinoma the leading cause of cancer-rela

indecipherable

Head and Neckc chemoradiation has become an accepted alternative to surgery and postoperative radiation therapy in advanced cancers. While systemic induction chemotherapy has proven an advantage in large trials for unresectable head and neck cancer and in case of larynx preservation, locoregional chemotherapy sh

ASTER

bibliophile

Nibble

HCCe to rise as the hepatitis C epidemic reaches maturity and nonalcoholic steatohepatitis becomes more prevalent. The incidence of HCC increases progressively with advancing age in all populations, reaching a peak at 70 years [2].